On Wednesday, in the course of current trade, Shares of Southwest Airlines Co. (NYSE:LUV), dropped -0.82%, and is now trading at $37.51.
Southwest Airlines, declared that its Flight Dispatchers, represented by the Transport Workers Union (TWU 550), have voted in favor of a new four-year contract. The agreement was ratified by 95 percent of Southwest’s Dispatchers and replaces the group’s previous contract well ahead of the November (2015) amendable date. The new collective bargaining agreement provides pay enhances, in addition to opportunities for bonuses tied to Company and Employee performance.
TWU 550 President Mike Connor said, “The Company values our Dispatchers, as evidenced by this agreement. This group works around the clock to support the operation and plays a vital role in getting our passengers to their destinations safely and efficiently. We are committed to Southwest and are enthusiastic about the future of our Company.”
FAA-licensed Dispatchers are directly responsible for the conduct of safe and efficient flight operations and the dispatch, clearance, and movement of all Company aircraft. Their new agreement supports the Company’s mission of providing its Employees a stable work environment and Southwest’s core vision of being the World’s Most Loved, Most Flown, and Most Profitable Airline.
Southwest Airlines Co. operates passenger airlines that provide planned air transportation services in the United States and near-international markets. As of December 31, 2014, it operated 665 Boeing 737 aircraft; and had 12 Boeing 717 aircraft.
During an Afternoon trade, Shares of Ignyta, Inc. (NASDAQ:RXDX), dipped -0.69%, and is now trading at $15.72.
LifeSci Capital, LLC, a research-driven investment bank with deep domain expertise in the life sciences sector, recently declared that it has initiated coverage of Ignyta, Inc. a precision medicine company developing oncology assets via an integrated drug and companion diagnostic approach known as Rx/Dx. Ignyta’s lead clinical candidate, entrectinib, is an oral, potential first-in-class tyrosine kinase inhibitor of TrkA, TrkB, TrkC, ROS1, and ALK. Entrectinib is presently being tested in two Phase I/II clinical studies.
Ignyta, Inc., a precision oncology biotechnology company, engages in discovering or acquiring, developing, and commercializing new drugs for cancer patients. Its products pipeline comprises of entrectinib, a tyrosine kinase inhibitor directed to the Trk family tyrosine kinase receptors, ROS1, and ALK proteins, which is in two Phase I/II clinical studies in molecularly defined patient populations for the treatment of solid tumors; and RXDX-103, a development program targeting the cell division cycle 7-related and protein kinase.
Shares of Capstone Turbine Corp. (NASDAQ:CPST), during its Wednesday’s current trading session gained 19.23%, and is now trading at $0.62.
Capstone Turbine Corporation, declared that it received an order for 25 C65 microturbines to fulfill the continual expansion of existing oil and gas customer fleets in shale plays across the western United States.
Horizon Power Systems, Capstone’s distributor for the Eagle Ford, Permian, Barnett, Mancos, San Juan, and Wattenberg Shale plays, secured the order, which is predictable to be commissioned later this year. The order will serve numerous facets of the shale oil and gas production process and assist to bolster aging infrastructures throughout these regions.
The natural-gas-fueled C65 microturbines will be installed in dual mode, which allows each customer to operate independently of the grid or with the grid in a load sharing capacity. Once commissioned, the microturbine systems will decrease the operating costs of key U.S. shale operations and ensure that reliable power is delivered to each site.
Capstone Turbine Corporation develops, manufactures, markets, and services microturbine technology solutions for use in stationary distributed power generation applications worldwide.
Finally, Atlantic Power Corporation (NYSE:AT), lost -0.17% Wednesday.
Atlantic Power Corporation, and Atlantic Power Preferred Equity Ltd. declared the dividend rate on the Corporation’s outstanding Cumulative Floating Rate Preferred Shares, Series 3 (AZP.PR.C) will be 4.79%, which will be payable September 30, 2015 .
The Series 3 Shares dividend rate was calculated on May 31, 2015 to be 4.79%, representing the sum of the Canadian Government 90-day Treasury Bill yield (using the three-month average result of 0.61%) plus 4.18%.
Atlantic Power Corporation owns and operates a fleet of power generation assets in the United States and Canada. As of December 31, 2014, its power generation projects in operation had an aggregate gross electric generation capacity of about 2,945 megawatts comprising of interests in 28 operational power generation projects across 11 states in the United States and 2 provinces in Canada.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
